Literature DB >> 23370404

Agreement for HPV genotyping detection between self-collected specimens on a FTA cartridge and clinician-collected specimens.

Yaoyao Guan1, Patti E Gravitt, Roslyn Howard, Yolanda J Eby, Shaoming Wang, Belinda Li, Changyan Feng, You-Lin Qiao, Philip E Castle.   

Abstract

The current method of transporting self-collected cervicovaginal specimen for HPV DNA testing relies on liquid based medium, which is challenging and expensive to transport. A novel, dry storage and transportation device, Whatman indicating FTA™ Elute Cartridge, avoids some of the pitfalls of liquid-based medium. This method has been shown to be comparable to liquid-based collection medium, but relative performance of self-collected (SC) and clinician-collected (CC) samples onto FTA cards has not been reported. The objective of this study is to compare the analytic performance of self- and clinician-collected samples onto FTA cartridges for the detection of carcinogenic HPV using Linear Array. There was a 91% agreement, 69% positive agreement, and kappa of 0.75 between the clinician-collected and self-collected specimens for detection of any carcinogenic HPV genotype. When the HPV results were categorized hierarchically according to cervical cancer risk, there was no difference in the distribution of the HPV results for the clinician- and self-collected specimens (p=0.7). This study concludes that FTA elute cartridge is a promising method of specimen transport for cervical cancer screening programs considering using self-collected specimen and HPV testing. Larger studies with clinical endpoints are now needed to assess the clinical performance.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23370404      PMCID: PMC4763924          DOI: 10.1016/j.jviromet.2012.11.010

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  17 in total

1.  Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge.

Authors:  Inger Gustavsson; Karin Sanner; Monica Lindell; Anders Strand; Matts Olovsson; Ingrid Wikström; Erik Wilander; Ulf Gyllensten
Journal:  J Clin Virol       Date:  2011-05-31       Impact factor: 3.168

2.  A cross-sectional study on the acceptability of self-collection for HPV testing among women in rural China.

Authors:  YaoYao Guan; Philip E Castle; Shaoming Wang; Belinda Li; Changyan Feng; Puwa Ci; Xue Li; Patti Gravitt; You-Lin Qiao
Journal:  Sex Transm Infect       Date:  2012-05-29       Impact factor: 3.519

3.  Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence.

Authors:  M Arbyn; E Paraskevaidis; P Martin-Hirsch; W Prendiville; J Dillner
Journal:  Gynecol Oncol       Date:  2005-09-09       Impact factor: 5.482

4.  Suitability of self-collected vaginal samples for cervical cancer screening in periurban villages in Andhra Pradesh, India.

Authors:  A Pavani Sowjanya; Proma Paul; Haripriya Vedantham; Gayatri Ramakrishna; D Vidyadhari; K Vijayaraghavan; Shantha Laksmi; Mrudula Sudula; Brigitte M Ronnett; Manik Das; Keerti V Shah; Patti E Gravitt
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

5.  Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results.

Authors:  Sudeshna Bandyopadhyay; R Marshall Austin; David Dabbs; Chengquan Zhao
Journal:  Arch Pathol Lab Med       Date:  2008-12       Impact factor: 5.534

6.  The indicating FTA elute cartridge a solid sample carrier to detect high-risk HPV and high-grade cervical lesions.

Authors:  Roosmarie P de Bie; Channa E Schmeink; Judith M J E Bakkers; Peter J F Snijders; Wim G V Quint; Leon F A G Massuger; Ruud L M Bekkers; Willem J G Melchers
Journal:  J Mol Diagn       Date:  2011-04-29       Impact factor: 5.568

7.  Patient acceptance of self-sampling for human papillomavirus in rural china.

Authors:  S Tisci; Y H Shen; D Fife; J Huang; J Goycoolea; C P Ma; J Belinson; Rui-De Huang; Y L Qiao
Journal:  J Low Genit Tract Dis       Date:  2003-04       Impact factor: 1.925

8.  Human papillomavirus (HPV) genotypes and HPV16 variants and risk of adenocarcinoma and squamous cell carcinoma of the cervix.

Authors:  M L Tornesello; S Losito; G Benincasa; F Fulciniti; G Botti; S Greggi; L Buonaguro; F M Buonaguro
Journal:  Gynecol Oncol       Date:  2011-01-06       Impact factor: 5.482

9.  Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPV.

Authors:  Inger Gustavsson; Monica Lindell; Erik Wilander; Anders Strand; Ulf Gyllensten
Journal:  J Clin Virol       Date:  2009-07-22       Impact factor: 3.168

10.  HPV screening for cervical cancer in rural India.

Authors:  Rengaswamy Sankaranarayanan; Bhagwan M Nene; Surendra S Shastri; Kasturi Jayant; Richard Muwonge; Atul M Budukh; Sanjay Hingmire; Sylla G Malvi; Ranjit Thorat; Ashok Kothari; Roshan Chinoy; Rohini Kelkar; Shubhada Kane; Sangeetha Desai; Vijay R Keskar; Raghevendra Rajeshwarkar; Nandkumar Panse; Ketayun A Dinshaw
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

View more
  8 in total

Review 1.  Intricacies of assessing the human microbiome in epidemiologic studies.

Authors:  Courtney K Robinson; Rebecca M Brotman; Jacques Ravel
Journal:  Ann Epidemiol       Date:  2016-04-12       Impact factor: 3.797

Review 2.  Molecular oncology testing in resource-limited settings.

Authors:  Margaret L Gulley; Douglas R Morgan
Journal:  J Mol Diagn       Date:  2014-09-19       Impact factor: 5.568

3.  HPV Testing from Dried Urine Spots as a Tool for Cervical Cancer Screening in Low-Income Countries.

Authors:  Elena Rosanna Frati; Marianna Martinelli; Ester Fasoli; Daniela Colzani; Silvia Bianchi; Sandro Binda; Pierfranco Olivani; Elisabetta Tanzi
Journal:  Biomed Res Int       Date:  2015-06-09       Impact factor: 3.411

4.  Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses.

Authors:  Marc Arbyn; Sara B Smith; Sarah Temin; Farhana Sultana; Philip Castle
Journal:  BMJ       Date:  2018-12-05

5.  Feasibility and accuracy evaluation of three human papillomavirus assays for FTA card-based sampling: a pilot study in cervical cancer screening.

Authors:  Shao-Ming Wang; Shang-Ying Hu; Wen Chen; Feng Chen; Fang-Hui Zhao; Wei He; Xin-Ming Ma; Yu-Qing Zhang; Jian Wang; Priya Sivasubramaniam; You-Lin Qiao
Journal:  BMC Cancer       Date:  2015-11-04       Impact factor: 4.430

6.  Randomized Comparison of Two Vaginal Self-Sampling Methods for Human Papillomavirus Detection: Dry Swab versus FTA Cartridge.

Authors:  Rosa Catarino; Pierre Vassilakos; Aline Bilancioni; Mathieu Vanden Eynde; Ulrike Meyer-Hamme; Pierre-Alain Menoud; Frédéric Guerry; Patrick Petignat
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

7.  An Evaluation of the Cobas4800 HPV Test on Cervico-Vaginal Specimens in Liquid versus Solid Transport Media.

Authors:  Hongxue Luo; Hui Du; Kathryn Maurer; Jerome L Belinson; Guixiang Wang; Zhihong Liu; Lijie Zhang; Yanqiu Zhou; Chun Wang; Jinlong Tang; Xinfeng Qu; Ruifang Wu
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

8.  Acceptability of self- collection for human papillomavirus detection in the Eastern Cape, South Africa.

Authors:  Ongeziwe Taku; Tracy L Meiring; Inger Gustavsson; Keletso Phohlo; Mirta Garcia-Jardon; Zizipho Z A Mbulawa; Charles B Businge; Ulf Gyllensten; Anna-Lise Williamson
Journal:  PLoS One       Date:  2020-11-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.